389 related articles for article (PubMed ID: 38732176)
21. Gastrointestinal infection-related disseminated intravascular coagulation mimicking Shiga toxin-mediated hemolytic uremic syndrome - implications of classical clinical indexes in making the diagnosis: A case report and literature review.
Li XY; Mai YF; Huang J; Pai P
World J Clin Cases; 2019 Jul; 7(13):1660-1670. PubMed ID: 31367625
[TBL] [Abstract][Full Text] [Related]
22. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
Abe T; Sasaki A; Ueda T; Miyakawa Y; Ochiai H
Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
[TBL] [Abstract][Full Text] [Related]
23. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
[TBL] [Abstract][Full Text] [Related]
24. [Ocular manifestations of primary thrombotic microangiopathy].
Smirnova TV; Kozlovskaya NL; Sheludchenko VM
Vestn Oftalmol; 2021; 137(5):138-144. PubMed ID: 34726868
[TBL] [Abstract][Full Text] [Related]
25. [Complement-mediated hemolytic uremic syndrome: a diagnostic approach].
Wieliczko M; Twardowska-Kawalec M
Wiad Lek; 2019; 72(11 cz 2):2239-2244. PubMed ID: 31860845
[TBL] [Abstract][Full Text] [Related]
26. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
27. Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report.
Kourouklaris A; Ioannou K; Athanasiou I; Panagidou A; Demetriou K; Zavros M
J Med Case Rep; 2014 Sep; 8():307. PubMed ID: 25219386
[TBL] [Abstract][Full Text] [Related]
28. Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.
Gavriilaki E; Anagnostopoulos A; Mastellos DC
Front Immunol; 2019; 10():337. PubMed ID: 30891033
[TBL] [Abstract][Full Text] [Related]
29. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
[TBL] [Abstract][Full Text] [Related]
30. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
31. Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know.
Vincent JL; Castro P; Hunt BJ; Jörres A; Praga M; Rojas-Suarez J; Watanabe E
Crit Care; 2018 Jun; 22(1):158. PubMed ID: 29895296
[No Abstract] [Full Text] [Related]
32. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
33. [Thrombotic microangiopathy].
Schmidt T; Huber TB
Med Klin Intensivmed Notfmed; 2023 Feb; 118(1):14-20. PubMed ID: 36633606
[TBL] [Abstract][Full Text] [Related]
34. Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
Masuda E; Fukushima K; Hebisawa Y; Tanaka M; Ohta A; Imamura A
Medicine (Baltimore); 2023 Oct; 102(41):e35469. PubMed ID: 37832064
[TBL] [Abstract][Full Text] [Related]
35. Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report.
Stoll SE; Werner P; Wetsch WA; Dusse F; Bunck AC; Kochanek M; Popp F; Schmidt T; Bruns C; Böttiger BW
J Med Case Rep; 2022 Jul; 16(1):271. PubMed ID: 35821156
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
Rubio-Haro R; Quesada-Carrascosa M; Hernández-Laforet J; Ferrer Gómez C; De Andrés J
Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar; 69(3):179-182. PubMed ID: 35283062
[TBL] [Abstract][Full Text] [Related]
37. [Thrombotic microangiopathy mimicking a heparin-induced thrombocytopenia].
Huynh-Moynot S; Eyrieux S; Moynot JC; Commandeur D; Fourel D; Ould-Ahmed M; Drouillard I
Ann Biol Clin (Paris); 2013; 71(1):113-9. PubMed ID: 23396435
[TBL] [Abstract][Full Text] [Related]
38. Thrombotic microangiopathy in children.
Palma LMP; Vaisbich-Guimarães MH; Sridharan M; Tran CL; Sethi S
Pediatr Nephrol; 2022 Sep; 37(9):1967-1980. PubMed ID: 35041041
[TBL] [Abstract][Full Text] [Related]
39. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
40. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
